Cargando…

Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer

Hypoxia-induced alternative splicing is a potent driving force in tumour pathogenesis and progression. In this review, we update currents concepts of hypoxia-induced alternative splicing and how it influences tumour biology. Following brief descriptions of tumour-associated hypoxia and the pre-mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farina, Antonietta Rosella, Cappabianca, Lucia, Sebastiano, Michela, Zelli, Veronica, Guadagni, Stefano, Mackay, Andrew Reay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294618/ https://www.ncbi.nlm.nih.gov/pubmed/32536347 http://dx.doi.org/10.1186/s13046-020-01616-9

Ejemplares similares

A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target
por: Cappabianca, Lucia, et al.
Publicado: (2019)

Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
por: Farina, Antonietta Rosella, et al.
Publicado: (2021)

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A
por: Guadagni, Stefano, et al.
Publicado: (2020)

Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells
por: Cappabianca, Lucia, et al.
Publicado: (2022)

Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood
por: Sbaffone, Maddalena, et al.
Publicado: (2022)

Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma
por: Cappabianca, Lucia, et al.
Publicado: (2019)

The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma
por: Cappabianca, Lucia, et al.
Publicado: (2023)

TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation
por: Farina, Antonietta Rosella, et al.
Publicado: (2017)

Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity
por: Farina, Antonietta Rosella, et al.
Publicado: (2015)

TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma
por: Gneo, Luciana, et al.
Publicado: (2016)

The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII
por: Farina, Antonietta Rosella, et al.
Publicado: (2018)

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
por: Farina, Antonietta Rosella, et al.
Publicado: (2014)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)

Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
por: Guadagni, Stefano, et al.
Publicado: (2020)

Hypoxia-Induced Alternative Splicing in Endothelial Cells
por: Weigand, Julia E., et al.
Publicado: (2012)

Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival
por: Guadagni, S., et al.
Publicado: (2019)

Alternative Splicing and Hypoxia Puzzle in Alzheimer’s and Parkinson’s Diseases
por: Jakubauskienė, Eglė, et al.
Publicado: (2021)

Transcriptome analysis of clock disrupted cancer cells reveals differential alternative splicing of cancer hallmarks genes
por: Malhan, Deeksha, et al.
Publicado: (2022)

Splicing regulatory factors in breast cancer hallmarks and disease progression
por: Koedoot, Esmee, et al.
Publicado: (2019)

A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer
por: Guadagni, Stefano, et al.
Publicado: (2020)

Splicing: is there an alternative contribution to Parkinson’s disease?
por: La Cognata, Valentina, et al.
Publicado: (2015)

Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study
por: Fiorentini, Giammaria, et al.
Publicado: (2020)

Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype
por: Barathova, M, et al.
Publicado: (2008)

Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases
por: Guadagni, Stefano, et al.
Publicado: (2022)

Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2020)

The TrkAIII Oncoprotein Inhibits Mitochondrial Free Radical ROS-Induced Death of SH-SY5Y Neuroblastoma Cells by Augmenting SOD2 Expression and Activity at the Mitochondria, within the Context of a Tumour Stem Cell-like Phenotype
por: Ruggeri, Pierdomenico, et al.
Publicado: (2014)

TrkAIII Promotes Microtubule Nucleation and Assembly at the Centrosome in SH-SY5Y Neuroblastoma Cells, Contributing to an Undifferentiated Anaplastic Phenotype
por: Farina, Antonietta R., et al.
Publicado: (2013)

Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells
por: Han, Jian, et al.
Publicado: (2017)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
por: Lippert, Timothy P., et al.
Publicado: (2021)

Alternative Splice in Alternative Lice
por: Tovar-Corona, Jaime M., et al.
Publicado: (2015)

Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma
por: Khurshid, Safiya, et al.
Publicado: (2022)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
por: Bowler, Elizabeth, et al.
Publicado: (2018)

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2016)

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
por: Madan, Vikas, et al.
Publicado: (2015)

CYP11B1 variants influence skeletal maturation via alternative splicing
por: Grgic, Olja, et al.
Publicado: (2021)

Alternative splicing signature of alveolar type II epithelial cells of Tibetan pigs under hypoxia-induced
por: Yuan, Haonan, et al.
Publicado: (2022)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

Alternative splicing in cardiomyopathy
por: Beqqali, A.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t3plsodp4a2tv2fn75l3s7kcah